PT Darya-Varia Laboratoria Tbk (DVLA.JK)

IDR 1600.0

(-1.23%)

Market Cap (In IDR)

1792 Billion

Revenue (In IDR)

1890.88 Billion

Net Income (In IDR)

146.33 Billion

Avg. Volume

37.17 Thousand

Currency
IDR
Country
Healthcare
Open
-
Prev. Close
-
Day Range
-
Year Range
1375.0-1850.0
PE
-
EPS
-
Beta Value
-0.096
ISIN
ID1000117203
CUSIP
-
CIK
-
Shares
-
Earnings Annoncement
-

Company Profile

Sector
Healthcare
Industry
Drug Manufacturers - Specialty & Generic
CEO
Mr. Celso Paz Lim
Employee Count
-
Website
https://www.darya-varia.com
Ipo Date
2001-12-13
Details
PT Darya-Varia Laboratoria Tbk engages in the manufacture and trading of pharmaceutical products and cosmetics in Indonesia. It operates in three segments: Prescription Drugs, Consumer Health Products, and Export and Toll Manufacturing Services. It provides various prescription and consumer health products in antibiotic, antiparasit, antiseptic, anti-fungal, cough and cold, cardiology, central nervous system, gastro-hepatology, somatic, vitamin and food supplement, women healthcare, ear healthcare, and derma medic areas. The company also exports its products to Malaysia, Myanmar, the Philippines, Singapore, Vietnam, and Mongolia. The company was founded in 1976 and is headquartered in Jakarta, Indonesia. PT Darya-Varia Laboratoria Tbk is a subsidiary of Blue Sphere Singapore Pte. Ltd.